Evidence map›Paper›PMID 33232327›Full record

ArticlePloS one2020

How scars shape the neural landscape: Key molecular mediators of TGF-β1's anti-neuritogenic effects.

Kye-Im Jeon, Krystel R Huxlin

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Kye-Im JeonThe Flaum Eye Institute, University of Rochester, Rochester, NY, United States of America.
Krystel R HuxlinThe Flaum Eye Institute, University of Rochester, Rochester, NY, United States of America.ORCID 0000-0001-7138-6156
University of Rochester · US

Funding

VISUAL SCIENCE RESEARCH CTR SUPPORTP30EY001319 · NEI · UNIVERSITY OF ROCHESTER · PI Susana Marcos · 1985 to 2026
$17.5M
The role of PPAR{gamma} ligands in corneal wound healing and opticsR01EY015836 · NEI · UNIVERSITY OF ROCHESTER · PI HUXLIN, KRYSTEL R · 2004 to 2023
$7.1M
NEI NIH HHS P30 EY001319NEI NIH HHS R01 EY015836
6 · The paper itself

Abstract

Following injury to the peripheral and central nervous systems, tissue levels of transforming growth factor (TGF)-β1 often increase, which is key for wound healing and scarring. However, active wound regions and scars appear to inhibit process outgrowth by regenerating neurons. We recently showed that corneal wound myofibroblasts block corneal nerve regeneration in vivo, and sensory neurite outgrowth in vitro in a manner that relies critically on TGF-β1. In turn, delayed, abnormal re-innervation contributes to long-term sensory dysfunctions of the ocular surface. Here, we exposed morphologically and biochemically-differentiated sensory neurons from the ND7/23 cell line to TGF-β1 to identify the intracellular signals regulating these anti-neuritogenic effects, contrasting them with those of Semaphorin(Sema)3A, a known inhibitor of neurite outgrowth. Neuronal morphology was quantified using phase-contrast imaging. Western blotting and specific inhibitors were then used to identify key molecular mediators. Differentiated ND7/23 cells expressed neuron-specific markers, including those involved in neurite extension and polarization. TGF-β1 increased phosphorylation of collapsin response mediator protein-2 (CRMP2), a molecule that is key for neurite extension. We now show that both glycogen synthase kinase (GSK)-3β and Smad3 modulate phosphorylation of CRMP2 after treatment with TGF-β1. GSK-3β appeared to exert a particularly strong effect, which could be explained by its ability to phosphorylate not only CRMP2, but also Smad3. In conclusion, TGF-β1's inhibition of neurite outgrowth in sensory neurons appears to be regulated through a highly-conserved signaling pathway, which involves the GSK-3β/CRMP-2 loop via both canonical and non-canonical mechanisms. It is hoped that by defining the signaling pathways that control neurite outgrowth in wound environments, it will become possible to identify optimal molecular targets to promote re-innervation following injury.

Indexed as

AnimalsCell DifferentiationCell LineGlycogen Synthase Kinase 3 betaIntercellular Signaling Peptides and ProteinsMiceMicroscopy, Phase-ContrastNerve Growth FactorNerve Tissue ProteinsNeuronsPhosphorylationSemaphorin-3ASignal TransductionSmad3 ProteinTransforming Growth Factor beta1collapsin response mediator protein-2Glycogen Synthase Kinase 3 betaGsk3b protein, mouseIntercellular Signaling Peptides and ProteinsNerve Growth FactorNerve Tissue ProteinsSemaphorin-3ASmad3 ProteinSmad3 protein, mouseTransforming Growth Factor beta1

Identifiers

PMID33232327
PMCPMC7685464
OpenAlexW3106723221

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.